BRAFV600E Mutation in a Histiocytic Sarcoma Arising From Hairy Cell Leukemia-Reference-Cited by-同舟云学术

BRAFV600E Mutation in a Histiocytic Sarcoma Arising From Hairy Cell Leukemia

Published:2014-12-10 Issue:35 Volume:32 Page:e117-e121
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Michonneau David¹,Kaltenbach Sophie¹,Derrieux Coralie¹,Trinquand Amelie¹,Brouzes Chantal¹,Gibault Laure²,North Marie-Odile³,Delarue Richard¹,Varet Bruno¹,Emile Jean-François⁴,Brousse Nicole¹,Hermine Olivier¹

Affiliation:

1. Hôpital Necker, Assistance Publique–Hôpitaux de Paris; and Université Paris Descartes, Sorbonne Paris Cite, Institut Hospitalo-Universitaire Imagine, Paris, France

2. Hôpital Cochin, Assistance Publique–Hôpitaux de Paris; and Université Paris Descartes, Sorbonne Paris Cite, Institut Hospitalo-Universitaire Imagine, Paris, France

3. Hôpital Cochin, Assistance Publique–Hôpitaux de Paris, Paris, France

4. Université de Versailles and Hôpital Ambroise Paré, Assistance Publique–Hôpitaux de Paris, Paris, France

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Reference21 articles.

1. BRAFMutations in Hairy-Cell Leukemia

2. BRAF Inhibition in Refractory Hairy-Cell Leukemia

3. Prognostic Value of BRAF V600 Mutations in Melanoma Patients After Resection of Metastatic Lymph Nodes

4. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

5. Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review and a case of rare Rosai-Dorfman disease;Biotechnology & Biotechnological Equipment;2024-09-10

2. Rapid but nondurable response of a BRAF exon 15 double-mutated spindle cell sarcoma to a combination of BRAF and MEK inhibitors;Oncotarget;2024-07-17

3. Long-Term Remission with Novel Combined Immune-Targeted Treatment for Histiocytic Sarcoma Accompanied by Follicular Lymphoma: Case Report and Literature Review;International Journal of Molecular Sciences;2024-07-02

4. Population Pharmacokinetics, Pharmacodynamics and Safety Properties of Trametinib in Dogs With Cancer: A Phase I Dose Escalating Clinical Trial;Veterinary and Comparative Oncology;2024-06-18

5. One Health: Therapies Targeting Genetic Variants in Human and Canine Histiocytic and Dendritic Cell Sarcomas;Veterinary and Comparative Oncology;2024-06-12